Cargando…
Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England
BACKGROUND: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and quetiapine immediate release (IR) prescribed to patients with a clinical diagnosis of schizophrenia, and/or manic episodes associated with bipolar disorder...
Autores principales: | Osborne, Vicki, Davies, Miranda, Evans, Alison, Shakir, Saad A. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476334/ https://www.ncbi.nlm.nih.gov/pubmed/32953041 http://dx.doi.org/10.1177/2045125320954616 |
Ejemplares similares
-
Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study
por: Evans, Alison, et al.
Publicado: (2020) -
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study
por: Evans, Alison, et al.
Publicado: (2020) -
CancerSCEM: a database of single-cell expression map across various human cancers
por: Zeng, Jingyao, et al.
Publicado: (2021) -
Specialist Cohort Event Monitoring Studies: A New Study Method for Risk Management in Pharmacovigilance
por: Layton, Deborah, et al.
Publicado: (2015) -
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
por: Davies, Miranda, et al.
Publicado: (2020)